Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacks

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 15, Issue 1, 2015, Pages 101-103

  Ismail, Sharif ^a   Cheng, Leo ^b   Grigoriadou, Sofia ^a   Laffan, James ^a   Menon, Manoj ^c  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Angioedema; Bradykinin; C1 esterase inhibitor; Steroid

Indexed keywords

ADRENALIN; BENDROFLUMETHIAZIDE; BRADYKININ; CHLORPHENIRAMINE; CHLORPHENIRAMINE MALEATE; COMPLEMENT; COMPLEMENT COMPONENT C1S INHIBITOR; DEXAMETHASONE; HYDROCORTISONE; ICATIBANT; TRANEXAMIC ACID; STEROID;

ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; B LYMPHOCYTE; CASE REPORT; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSPNEA; FACE EDEMA; FEMALE; HOARSENESS; HUMAN; HYPERTENSION; INSECT BITE; INTENSIVE CARE; LARYNX; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MASTOCYTOSIS; MIDDLE AGED; MOUTH EDEMA; NASOPHARYNX; NONHODGKIN LYMPHOMA; OROPHARYNX; RESPIRATORY TRACT INTUBATION; STEROID THERAPY; SWELLING; THYROID NODULE; TRACHEOSTOMY; TRACHEOSTOMY TUBE; ANGIOEDEMA; ANTAGONISTS AND INHIBITORS; DIFFERENTIAL DIAGNOSIS; PATHOPHYSIOLOGY; RECURRENT DISEASE;

ANGIOEDEMA; BRADYKININ; COMPLEMENT C1 INHIBITOR PROTEIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; RECURRENCE; STEROIDS;

EID: 85003049564     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.15-1-101     Document Type: Article

References (8)

1. Jaiganesh T, Wiese M, Hollingsworth J et al. Acute angioedema: recognition and management in the emergency department. Eur J Emerg Med 2013;20:10-7.
2. Jolles S, Williams P, Carne E et al. A UK national audit of hereditary and acquired angioedema. A UK national audit of hereditary and acquired angioedema. Clin Exp Immunol 2014;175:59-67.
3. Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol 2010;6:14-8.
4. Zanichelli A, Bova M, Coerezza A et al. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. Allergy 2012;67:1074-7.
5. Drug Development Technology. Kalbitor - treatment for hereditary angioedema. 2014. Available online at www.drugdevelopmenttechnology.com/projects/dyax-corps-kalbitor/[Accessed 22 September 2014].
6. Castelli R, Zanichelli A, Cicardi M, Cugno M. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship. Crit Rev Oncol Hematol 2013;87:323-32.
7. Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C. Clinical and biological distinctions between type I and type II acquired angioedema. Am J Med 2003;115:420-1.
8. Zuraw BL, Bernstein JA, Lang DM et al. A focused parameter update: hereditary angioedema, acquired C1-esterase inhibitor deficiency, and angiotensin converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol 2013:131; 1491-93.e25.